New England Capital Financial Advisors LLC Heron Therapeutics, Inc. Transaction History
New England Capital Financial Advisors LLC
- $205 Billion
- Q4 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 475 shares of HRTX stock, worth $769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
475
Previous 475
-0.0%
Holding current value
$769
Previous $946,000
23.15%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
174Shares Held
118MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$43.3 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$14.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$13.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$13.2 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$11.3 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $192M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...